Skip to content
Screener

Stryker SYK Hips — Net Sales

Other product segments

Trauma and Extremities
$1.04B+9.5%
Instruments
$920M+9.8%
Medical
$902M-4.6%
Endoscopy
$868M+0.1%
Knees
$670M+4.9%
Ortho Tech
$646M—
Vascular
$517M+27.3%
Spine
$8M-95.7%

Similar metrics at other companies

The Marzetti Company logo
MZTIRefrigerated dressings, dips and other — Net Sales
$41.56M+2.3%
POS
POSTNut butters — Net Sales
$101.3M+392%
POS
POSTPet Food — Net Sales
$346.7M-19.9%
Otis Worldwide logo
OTISService sales — Net Sales
$2.58B+11.3%
Central Garden & Pet Company logo
CENTPet — Net Sales
$476.84M+5.1%
Central Garden & Pet Company logo
CENTOther pet products — Net Sales
$164M+7.3%

Other financials

Income statement

See full
Revenue$6.6B+9.4%
Gross profit$4.5B+17.1%
Operating income$1.7B+49.1%
Net income$1.3B+44.3%
EPS (diluted)$3.30+44.1%

Balance sheet

See full
Cash & equivalents$3.4B+42.8%
Total debt$14.2B-15.2%
Total assets$47.9B+3.5%

Cash flow

See full
Operating cash flow$1.3B+13.5%
CapEx$202.0M+10.4%
Free cash flow$1.1B+14.1%

Valuation

See full
Market cap$124.86B-14.4%
Enterprise value$135.66B-15.3%
P/E33.5×-16.5×
P/S4.8×-1.3×

Profitability

See full
Gross margin65%+0.8pp
Operating margin21.4%+6.2pp
Net margin14.4%+2.2pp
FCF margin18.2%+1.3pp

Returns & leverage

See full
Return on equity32.8%—
Debt / equity0.8×—
Current ratio2.2×+0.4×

Where this comes from

Reported directly by Stryker in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The source filing: Stryker’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 11:10 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000310764-26-000031
Net Sales by BusinessThree Months / 2026Three Months / 2025
$3,207$3,056
Orthopaedics:
Knees$670$639
Hips460443
Trauma and Extremities1,035945
Ortho Tech646617
Spinal Implants2166
$2,813$2,810

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Stryker's hips — net sales?
Stryker (SYK) reported hips — net sales of $460M in Q1 2026.
How has Stryker's hips — net sales changed year-over-year?
Stryker's hips — net sales increased by 3.8% year-over-year, from $443M to $460M.
What is the long-term trend for Stryker's hips — net sales?
Over 4 years (2021 to 2025), Stryker's hips — net sales has grown at a 8.6% compound annual growth rate (CAGR), from $1.34B to $1.87B.
What does hips — net sales mean?
This metric represents the total revenue generated from the sale of hip reconstructive implants and related surgical instrumentation. It reflects the company's market performance within the orthopedic joint replacement sector, capturing demand for both primary and revision hip arthroplasty procedures. As a core segment, it serves as a key indicator of the company's competitive positioning and growth trajectory in the reconstructive implant market.

Ask your AI about Stryker's hips — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude